Constitutional mismatch repair deficiency in childhood colorectal cancer harboring a de novo variant in the MSH6 gene: a case report.


Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
10 Feb 2021
Historique:
received: 05 11 2020
accepted: 04 02 2021
entrez: 11 2 2021
pubmed: 12 2 2021
medline: 15 5 2021
Statut: epublish

Résumé

Constitutional mismatch repair deficiency (CMMRD) is caused by biallelic pathogenic variants in one of the mismatch repair genes, and results in early onset colorectal cancer, leukemia, brain tumors and other childhood malignancies. Here we report a case of CMMRD with compound heterozygous variants in the MSH6 gene, including a de novo variant in multiple colorectal cancers. An 11-year-old girl, who presented with multiple spots resembling café-au-lait macules since birth, developed abdominal pain, diarrhea and bloody stool over two months. Colonoscopy revealed multiple colonic polyps, including a large epithelial tumor, and pathological examination revealed tubular adenocarcinoma. Brain magnetic resonance imaging (MRI) showed an unidentified bright object (UBO), commonly seen in neurofibromatosis type 1 (NF1). Genetic testing revealed compound heterozygous variants, c. [2969T > A (p.Leu990*)] and [3064G > T (p.Glu1022*)] in the MSH6 gene; c.2969T > A (p.Leu990*) was identified as a de novo variant. We present the first report of a CMMRD patient with a de novo variant in MSH6, who developed colorectal cancer in childhood. CMMRD symptoms often resemble NF1, as observed here. Physicians should become familiar with CMMRD clinical phenotypes for the screening and early detection of cancer.

Sections du résumé

BACKGROUND BACKGROUND
Constitutional mismatch repair deficiency (CMMRD) is caused by biallelic pathogenic variants in one of the mismatch repair genes, and results in early onset colorectal cancer, leukemia, brain tumors and other childhood malignancies. Here we report a case of CMMRD with compound heterozygous variants in the MSH6 gene, including a de novo variant in multiple colorectal cancers.
CASE PRESENTATION METHODS
An 11-year-old girl, who presented with multiple spots resembling café-au-lait macules since birth, developed abdominal pain, diarrhea and bloody stool over two months. Colonoscopy revealed multiple colonic polyps, including a large epithelial tumor, and pathological examination revealed tubular adenocarcinoma. Brain magnetic resonance imaging (MRI) showed an unidentified bright object (UBO), commonly seen in neurofibromatosis type 1 (NF1). Genetic testing revealed compound heterozygous variants, c. [2969T > A (p.Leu990*)] and [3064G > T (p.Glu1022*)] in the MSH6 gene; c.2969T > A (p.Leu990*) was identified as a de novo variant.
CONCLUSIONS CONCLUSIONS
We present the first report of a CMMRD patient with a de novo variant in MSH6, who developed colorectal cancer in childhood. CMMRD symptoms often resemble NF1, as observed here. Physicians should become familiar with CMMRD clinical phenotypes for the screening and early detection of cancer.

Identifiants

pubmed: 33568103
doi: 10.1186/s12876-021-01646-3
pii: 10.1186/s12876-021-01646-3
pmc: PMC7876783
doi:

Substances chimiques

DNA-Binding Proteins 0
G-T mismatch-binding protein 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

60

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : 18kk0205004
Organisme : Japan Society for the Promotion of Science
ID : JP18K07339

Références

J Pediatr. 2001 May;138(5):629-35
pubmed: 11343035
Pediatr Clin North Am. 2010 Oct;57(5):1131-53
pubmed: 20888463
J Med Genet. 2019 Feb;56(2):53-62
pubmed: 30415209
Hum Genet. 2003 Feb;112(2):117-23
pubmed: 12522551
J Pediatr Surg. 1999 Oct;34(10):1499-504
pubmed: 10549756
Cancer Res. 1999 Jan 15;59(2):294-7
pubmed: 9927034
Hum Genet. 2008 Sep;124(2):105-22
pubmed: 18709565
Clin Genet. 2017 Apr;91(4):507-519
pubmed: 27779754
Gut. 2006 Dec;55(12):1781-8
pubmed: 16636019
J Med Genet. 2011 Aug;48(8):530-4
pubmed: 21636617
Pediatr Surg Int. 2009 Dec;25(12):1073-6
pubmed: 19816697
Clin Genet. 2018 Jan;93(1):134-137
pubmed: 28503822
Cancer Res. 1998 Nov 15;58(22):5248-57
pubmed: 9823339
Cancer Res. 1999 Jan 15;59(2):290-3
pubmed: 9927033
J Med Genet. 2014 Jun;51(6):355-65
pubmed: 24737826
Eur J Pediatr. 2008 Oct;167(10):1213-5
pubmed: 18183421
Front Immunol. 2018 Jul 02;9:1506
pubmed: 30013564

Auteurs

Keinosuke Hizuka (K)

Department of Gastroenterology, Nutrition and Endocrinology, Osaka Women's and Children's Hospital, 840 Murodo-cho, Izumi, Osaka, 594-1101, Japan.

Shin-Ichiro Hagiwara (SI)

Department of Gastroenterology, Nutrition and Endocrinology, Osaka Women's and Children's Hospital, 840 Murodo-cho, Izumi, Osaka, 594-1101, Japan. hagi114@wch.opho.jp.

Takatoshi Maeyama (T)

Department of Gastroenterology, Nutrition and Endocrinology, Osaka Women's and Children's Hospital, 840 Murodo-cho, Izumi, Osaka, 594-1101, Japan.

Hitoshi Honma (H)

Department of Gastroenterology, Nutrition and Endocrinology, Osaka Women's and Children's Hospital, 840 Murodo-cho, Izumi, Osaka, 594-1101, Japan.

Masanobu Kawai (M)

Department of Gastroenterology, Nutrition and Endocrinology, Osaka Women's and Children's Hospital, 840 Murodo-cho, Izumi, Osaka, 594-1101, Japan.

Kiwamu Akagi (K)

Division of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, 780, Komuro, Ina-machi, Kitaadachi-gun, Saitama, 780362-0806, Japan.

Michiko Yasuhara (M)

Division of Lower GI Surgery, Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.

Naohiro Tomita (N)

Division of Lower GI Surgery, Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.
Cancer Treatment Center, Toyonaka Municipal Hospital, 4-14-1, Shibahara-cho, Toyonaka, Osaka, 560-8565, Japan.

Yuri Etani (Y)

Department of Gastroenterology, Nutrition and Endocrinology, Osaka Women's and Children's Hospital, 840 Murodo-cho, Izumi, Osaka, 594-1101, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH